mhurhangee/ep-ind-claims huggingface dataset:
A surgical stapler (200, 700) for treating the tissue of a patient, comprising: a handle (210, 710); a shaft (140, 734) extending from said handle; an end effector extending from said shaft, comprising: a first jaw; a second jaw, wherein one of said first jaw and said second jaw is movable relative to the other; a cartridge body including staple cavities; staples removably stored in said staple cavities; and an anvil configured to deform said staples; a firing system (130, 136, 630, 736) configured to: eject said staples from said staple cavities toward said anvil during a firing stroke; and cut the tissue during a cutting stroke after said firing stroke has been completed; and means for permitting the user of the surgical instrument to elect whether to perform said cutting stroke with said surgical stapler after said firing stroke, characterized in that said means comprises a stop configured to stop said firing system after said firing stroke and before said cutting stroke, and wherein said stop is selectively releasable by the user of said surgical stapler. a handle (210, 710); a shaft (140, 734) extending from said handle; an end effector extending from said shaft, comprising: a first jaw; a second jaw, wherein one of said first jaw and said second jaw is movable relative to the other; a cartridge body including staple cavities; staples removably stored in said staple cavities; and an anvil configured to deform said staples; a first jaw; a second jaw, wherein one of said first jaw and said second jaw is movable relative to the other; a cartridge body including staple cavities; staples removably stored in said staple cavities; and an anvil configured to deform said staples; a firing system (130, 136, 630, 736) configured to: eject said staples from said staple cavities toward said anvil during a firing stroke; and cut the tissue during a cutting stroke after said firing stroke has been completed; and eject said staples from said staple cavities toward said anvil during a firing stroke; and cut the tissue during a cutting stroke after said firing stroke has been completed; and means for permitting the user of the surgical instrument to elect whether to perform said cutting stroke with said surgical stapler after said firing stroke, characterized in that said means comprises a stop configured to stop said firing system after said firing stroke and before said cutting stroke, and wherein said stop is selectively releasable by the user of said surgical stapler.
A ceramic electronic component, comprising: a ceramic component body having two end surfaces to which internal electrodes (14, 16) are led and side surfaces connecting the two end surfaces; first external electrodes containing a metal sintered compact and formed in such a manner as to wrap around from the two end surfaces of the ceramic component body to a part of the side surfaces to be connected to the internal electrodes; and second external electrodes containing a conductive resin and formed in such a manner as to entirely cover the first external electrodes at the side surfaces of the ceramic component body, characterized in that the end of the first external electrode covered with the second electrode being apart from the side surface of the ceramic electronic component. a ceramic component body having two end surfaces to which internal electrodes (14, 16) are led and side surfaces connecting the two end surfaces; first external electrodes containing a metal sintered compact and formed in such a manner as to wrap around from the two end surfaces of the ceramic component body to a part of the side surfaces to be connected to the internal electrodes; and second external electrodes containing a conductive resin and formed in such a manner as to entirely cover the first external electrodes at the side surfaces of the ceramic component body, characterized in that the end of the first external electrode covered with the second electrode being apart from the side surface of the ceramic electronic component.
An orally administrable pharmaceutical composition comprising α,α,α-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl) methyl-2,4 (1H,3H)-pyrimidine dione hydrochloride as active ingredients and a sugar having a critical relative humidity of 85% or more at 25°C as an excipient, and comprising partly pregelatinized starch as a disintegrating agent, wherein the content of the disintegrating agent is from 2 to 16% by mass in the total amount of the pharmaceutical composition.
A method for wireless communications, comprising: obtaining an address for a visitor home agent, and at least a prefix portion of a home address for a mobile node, from a visited network, the visitor home agent being associated with the visited network to which the mobile node is attached; creating a home address for the mobile node by combining the prefix portion of the home address with an interface identifier negotiated with the visited network; and sending a binding update to the visitor home agent, the binding update including the home address and a care-of address associated with the mobile node. obtaining an address for a visitor home agent, and at least a prefix portion of a home address for a mobile node, from a visited network, the visitor home agent being associated with the visited network to which the mobile node is attached; creating a home address for the mobile node by combining the prefix portion of the home address with an interface identifier negotiated with the visited network; and sending a binding update to the visitor home agent, the binding update including the home address and a care-of address associated with the mobile node.
Compounds of the formula I in which X-Y denotes CO-NA" or NA"-CO, R 1 denotes Ar or Het, R 2 denotes H or CH 3, R 3 denotes H or CH 3, Ar denotes phenyl, which is unsubstituted or mono-, di- or trisubstituted by Hal, CN, A and/or OR 3, Het denotes pyrimidyl, pyridyl, pyridazinyl, pyrazinyl, piperidinyl, pyrrolidinyl, pyrazolyl, thiazolyl, imidazolyl, furanyl, thiophenyl, pyrrolyl, oxazolyl, triazolyl, oxadiazolyl or thiadiazolyl, each of which is unsubstituted or mono- or disubstituted by Hal, A, CN and/or OR 3, A denotes unbranched or branched alkyl with 1-6 C-atoms, wherein 1-5 H-atoms may be replaced by F, A" denotes unbranched or branched alkyl with 1-4 C-atoms, Hal denotes F, Cl, Br or I, and pharmaceutically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios. X-Y denotes CO-NA" or NA"-CO, R 1 denotes Ar or Het, R 2 denotes H or CH 3, R 3 denotes H or CH 3, Ar denotes phenyl, which is unsubstituted or mono-, di- or trisubstituted by Hal, CN, A and/or OR 3, Het denotes pyrimidyl, pyridyl, pyridazinyl, pyrazinyl, piperidinyl, pyrrolidinyl, pyrazolyl, thiazolyl, imidazolyl, furanyl, thiophenyl, pyrrolyl, oxazolyl, triazolyl, oxadiazolyl or thiadiazolyl, each of which is unsubstituted or mono- or disubstituted by Hal, A, CN and/or OR 3, A denotes unbranched or branched alkyl with 1-6 C-atoms, wherein 1-5 H-atoms may be replaced by F, A" denotes unbranched or branched alkyl with 1-4 C-atoms, Hal denotes F, Cl, Br or I,
A centrifugal-force pendulum device, in particular for a drive train of an internal combustion engine-driven motor vehicle, comprising a pendulum mass support part (2, 64, 72, 86) which can be rotated about an axis of rotation and at least one pendulum mass (11, 12, 13, 14) which can be displaced under the influence of centrifugal force arranged on the pendulum mass support part (2, 64, 72, 86), wherein the at least one pendulum mass (11, 12, 13, 14) is guided on the pendulum mass support part (2, 64, 72, 86) using at least one pendulum roller (25, 26, 35, 36, 44), the pendulum roller (25, 26, 35, 36, 44) having a pendulum roller axis of rotation, two first roller sections (52, 56), each with a first diameter, and a second roller section with a second diameter arranged between the first roller sections (52, 56) in the direction of extension of the pendulum roller axis of rotation, wherein the first diameter is smaller than the second diameter and a centring section (46, 48) designed as a ramp-like transition between the first diameter and the second diameter is arranged between each of the first roller sections (52, 56) and the second roller section, characterised in that the pendulum mass carrier part (2, 64, 72, 86) and/or the at least one pendulum mass (11, 12, 13, 14) has a sliding layer (80, 82).
A microfluidic device for conducting assays, comprising: (a) a main flow channel adapted to allow the flow of a solution therethrough; (b) a plurality of branch flow channels (916A,916B,916C), wherein each branch flow channel is in fluid communication with the main flow channel and comprises a detection region; (c) a plurality of control channels; and (d) a plurality of valves (936,940,944,946,948) operatively disposed with respect to the main flow channel and/or the plurality of branch flow channels (916A,916B,916C) to regulate flow of the solution through the main and branch flow channels, wherein each of the valves comprises one of the control channels and an elastomeric membrane that is deflectable into or retractable from the main or branch flow channel (916A,916B,916C) upon which the valve operates in response to an actuation force applied to the control channel, the elastomeric membrane when positioned in the flow channel restricting solution flow therethrough; and wherein the control channel of each valve (936,940,944,946,948) is separated from the flow channel in which the valve operates by the elastomeric membrane. (a) a main flow channel adapted to allow the flow of a solution therethrough; (b) a plurality of branch flow channels (916A,916B,916C), wherein each branch flow channel is in fluid communication with the main flow channel and comprises a detection region; (c) a plurality of control channels; and (d) a plurality of valves (936,940,944,946,948) operatively disposed with respect to the main flow channel and/or the plurality of branch flow channels (916A,916B,916C) to regulate flow of the solution through the main and branch flow channels, wherein each of the valves comprises one of the control channels and an elastomeric membrane that is deflectable into or retractable from the main or branch flow channel (916A,916B,916C) upon which the valve operates in response to an actuation force applied to the control channel, the elastomeric membrane when positioned in the flow channel restricting solution flow therethrough;
Bicycle with distinctive drive assembly having a tubular frame that includes a front handlebar that, by means of a fork, controls the front wheel, with said tubular frame being equipped with a central moving assembly that includes a sprocket having respective cranks, and being surrounded by a chain that continues toward the rear portion of the tubular frame, where a rear wheel, driven by a ratchet is located, said bicycle further comprising pedal boards wherein each of the pedal boards are mounted in a pivoting manner by their respective front fends on the ends of the respective cranks, whereby each of the pedal boards 2. are extended in the form of a guide rod; said guide rods being supported by a rear assembly containing sliding mountings, and being formed by transverse tube that is horizontally incorporated into the frame and accommodates a roller at each of its ends, said roller having a groove the size of which is intended to accommodate the cross-section of the guide rod, characterized in that said transverse tube being incorporated into the frame above and behind the rear wheel.
Apparatus for stimulating muscles in a patient, the apparatus comprising a garment incorporating a plurality of electrodes (A, B, C) for application to the patient's body, and drive circuitry arranged to energise the electrodes with current pulses, whereby the apparatus is designed for stimulating the lower back and abdominal muscles of the patient, the electrodes being positioned relative to the garment such that when the garment is worn a first electrode is applied to the lower lumbar region of the patient's body and second and third electrodes (B, C) are applied respectively to opposite side flanks of the patient's trunk, and in that the drive circuitry is adapted to apply a first group of muscular stimulation current pulses which flow between the second and third electrodes (B, C), characterised in that said drive circuitry is further adapted, such that pulses of the first group travel in opposite directions between the second and third electrodes, and said drive circuitry is adapted to apply a second group of muscular stimulation current pulses which flow between the first electrode and the second and third electrodes (B, C), wherein the first electrode comprises two individually energisable segments with a vertical gap therebetween which is configured to be aligned with the patient's spine when the garment is worn thereby locating the respective segments at opposite sides of the patient's midline, the first electrode extends between and covers at least the upper sacrum and the fifth lumber vertebra of the patient when the garment is worn; and the lower end of the first electrode forms a wedge shape which points into the patient's gluteal cleft when the garment is worn.
A memory controller comprising: a hardware interface to couple to a memory device; and command logic to generate a retry command for the memory device; wherein the retry command is to trigger the memory device to return read data without application of error checking and correction, ECC, by ECC circuitry of the memory device, wherein the command logic is to generate the retry command in response to receipt of error data received in response to a prior read command, the memory controller being characterised in that: the hardware interface is to receive an indication of a detected, uncorrectable error, DUE, from the memory device in response to the prior read command, and wherein the command logic is to generate the retry command in response to the indication of the DUE from the memory device. a hardware interface to couple to a memory device; and command logic to generate a retry command for the memory device; wherein the retry command is to trigger the memory device to return read data without application of error checking and correction, ECC, by ECC circuitry of the memory device, wherein the command logic is to generate the retry command in response to receipt of error data received in response to a prior read command, the memory controller being characterised in that: the hardware interface is to receive an indication of a detected, uncorrectable error, DUE, from the memory device in response to the prior read command, and wherein the command logic is to generate the retry command in response to the indication of the DUE from the memory device.
A composition comprising a melt processable polymer derived from a bio-based polymer and an acrylated silicone polyether wherein the bio-based polymer is selected from the group consisting of polysaccharides, peptides, aliphatic polyesters, polyamino acids, polyvinyl alcohol, polyamides, polyalkylene glycols, and copolymers thereof and wherein the melt processable polymer is produced by melt processing said bio-based polymer with the acrylated silicone polyether at temperatures that promote covalent reactions between the bio-based polymer and the acrylated silicone polyether.
A facility for the treatment of organic compounds comprising: • a first unit incorporating drying means suitable for the treatment of the organic compounds in order to obtain a substantially anhydrous material; • a second unit incorporating a first reactor to carry out a process of pyrolysis of the substantially anhydrous material to obtain a gaseous fraction and a solid fraction therefrom; • a third unit incorporating a second reactor to carry out a process of gasification of the solid fraction of the substantially anhydrous material to obtain a gaseous fraction and a solid fraction therefrom, and suitable for obtaining a gaseous mixture comprising the gaseous fraction obtained from the gasification process and the gaseous fraction of the substantially anhydrous material for the generation of electrical energy (E EL) and/or thermal energy; in which the first and second reactors (21, 31) comprise corresponding control means (22, 32) suitable for maintaining the pressure within the said first and second rectors (21, 31) during the pyrolysis and gasification processes at a value slightly above the atmospheric pressure in such a way as prevent the ingress of air from the exterior to interior of the reactors (21, 31), so that the processes take place substantially in the absence of ingress of oxidising agents coming from the external environment and in which a secondary part of the gaseous mixture is intended to feed combustion means to feed the pyrolysis and gasification processes when these processes reach steady-state conditions, in which the value of the pressure within the first and second reactors (21, 31) is greater than atmospheric pressure by a value of between 19.613 Pa and 98.064 Pa in the course of the pyrolysis and gasification processes. • a first unit incorporating drying means suitable for the treatment of the organic compounds in order to obtain a substantially anhydrous material; • a second unit incorporating a first reactor to carry out a process of pyrolysis of the substantially anhydrous material to obtain a gaseous fraction and a solid fraction therefrom; • a third unit incorporating a second reactor to carry out a process of gasification of the solid fraction of the substantially anhydrous material to obtain a gaseous fraction and a solid fraction therefrom, and suitable for obtaining a gaseous mixture comprising the gaseous fraction obtained from the gasification process and the gaseous fraction of the substantially anhydrous material for the generation of electrical energy (E EL) and/or thermal energy;
A compound having a structure wherein R 1, independently, is OC 1-3 alkyl substituted with one to five fluoro atoms; NR 2 R 2' is selected from the group consisting of 1-pyrrolidinyl, 3-fluoro-1-pyrrolidinyl, 1-morpholinyl, 1-azetidinyl, and 1-pyrrolidinyl-3-one; R 3 is H, F, or Cl; G is (CH 2) n; m is 1 or 2; and n is 1 or 2, or a pharmaceutically acceptable salt thereof. wherein R 1, independently, is OC 1-3 alkyl substituted with one to five fluoro atoms; NR 2 R 2' is selected from the group consisting of 1-pyrrolidinyl, 3-fluoro-1-pyrrolidinyl, 1-morpholinyl, 1-azetidinyl, and 1-pyrrolidinyl-3-one; R 3 is H, F, or Cl; G is (CH 2) n; m is 1 or 2; and n is 1 or 2,
A valve actuation apparatus, comprising: a mechanical activation device; a primer coupled to the mechanical activation device and configured to deflagrate upon activation by the mechanical activation device; an explosive cord, comprising an explosive cord first end coupled to the primer, an explosive cord second end, an outer portion, an inner portion, and an explosive cord reactive material, wherein the explosive cord reactive material is configured to detonate upon ignition from the primer and propagate a pressure wave and hot gas through a length of the explosive cord; a gas-generating device coupled to the explosive cord second end configured to be activated by the hot gas from the explosive cord and, in response to the hot gas, produce a gas; and a valve coupled to the gas-generating device, wherein the valve is moved from a valve closed position to a valve open position in response to the gas. a mechanical activation device; a primer coupled to the mechanical activation device and configured to deflagrate upon activation by the mechanical activation device; an explosive cord, comprising an explosive cord first end coupled to the primer, an explosive cord second end, an outer portion, an inner portion, and an explosive cord reactive material, wherein the explosive cord reactive material is configured to detonate upon ignition from the primer and propagate a pressure wave and hot gas through a length of the explosive cord; a gas-generating device coupled to the explosive cord second end configured to be activated by the hot gas from the explosive cord and, in response to the hot gas, produce a gas; and a valve coupled to the gas-generating device, wherein the valve is moved from a valve closed position to a valve open position in response to the gas.
A fragmentation device designed to fragment the glass of a used window, and comprising at least: - a conveyor designed to transport said window, flat, along a longitudinal axis, - at least one fragmentation assembly, surmounting the conveyor, and designed to fragment the glass of said window as it is being transported on said conveyor, said device being characterized in that the fragmentation assembly comprises a drum arranged above said conveyor along an axis of revolution transverse to said longitudinal axis, said drum being connected by at least one chain to at least one impactor assembly comprising at least one percussion head designed to strike the conveyor upon each revolution of said drum. - a conveyor designed to transport said window, flat, along a longitudinal axis, - at least one fragmentation assembly, surmounting the conveyor, and designed to fragment the glass of said window as it is being transported on said conveyor, said device being characterized in that the fragmentation assembly comprises a drum arranged above said conveyor along an axis of revolution transverse to said longitudinal axis, said drum being connected by at least one chain to at least one impactor assembly comprising at least one percussion head designed to strike the conveyor upon each revolution of said drum.
A microorganism whose xylose fermentation ability is increased, which is deficient in the function of expressing NAD kinase gene, which is further deficient in the function of expressing FPS1 gene.